LBP
Reactivité: Humain
WB, IHC (p)
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
ELISA, Immune histology at paraffin sections, LBP inhibition studies, Western Blot. No inhibition of LPS binding to membrane bound CD14 Binding titre at human LBP- ELISA: 1:10.000
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstitute with bidistilled water
Concentration
1 mg/mL
Buffer
PBS, pH 7.12
Agent conservateur
Without preservative
Stock
-20 °C,-80 °C
Eckert, Kim, Kim, Gürtler, Oh, Sur, Lundvall, Hamann, van der Ploeg, Pickkers, Giamarellos-Bourboulis, Kubarenko, Weber, Kabesch, Kumpf, An, Lee, Schumann: "The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity." dans: Immunity, Vol. 39, Issue 4, pp. 647-60, (2013) (PubMed).
Rahman, Lecchi, Avallone, Roccabianca, Sartorelli, Ceciliani: "Lipopolysaccharide-binding protein: Local expression in bovine extrahepatic tissues." dans: Veterinary immunology and immunopathology, (2010) (PubMed).
Ren, Jin, Leung: "Local expression of lipopolysaccharide-binding protein in human gingival tissues." dans: Journal of periodontal research, Vol. 39, Issue 4, pp. 242-8, (2004) (PubMed).
Antigène
LBP
(Lipopolysaccharide Binding Protein (LBP))
Autre désignation
Lipopolysaccharide (LPS)-Binding Protein (LBP) (LBP Produits)
Background: Natural Lipopolysccaride Binding Protein (LBP) is a 58KD glycoprotein produced in liver. It binds at lipid A of LPS with high affinity (10-9M) and reduced the cellular LPS effects at CD14+ cells (IL1ß, IL6, TNFα). It acts as opsonin for GRAM negative cells, LPS, neutrophiles and granulocytes.